Pharmacokinetics of Efavirenz 600mg in Combination with Rifampicin in Chinese HIV/TB Co-Infection Patients

BACKGROUND: Rifampicin is a known inducer of the cytochrome P450 (CYP2B6) enzyme, which can lead to a decrease in the concentration of efavirenz. Therefore, we conducted a study to evaluate the effect of daily rifampicin intake on efavirenz 600mg pharmacokinetics and HIV-1 virological suppression. M...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Tongtong, Liu, Yingchu, Zhu, Chunyu, Yang, Siyuan, Yang, Di, Xiao, Jiang, Gao, Guiju
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10361278/
https://www.ncbi.nlm.nih.gov/pubmed/37484907
http://dx.doi.org/10.2147/IDR.S415749

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10361278/
https://www.ncbi.nlm.nih.gov/pubmed/37484907
http://dx.doi.org/10.2147/IDR.S415749

Ejemplares similares